Browsing articles tagged with " jon najarian"
The Najarian brothers are in Las Vegas to do some re-takes for Hangover 3. They play a couple of gamblers whose suitcase full of cash is
Funds will review your basic reason nls cash advance nls cash advance the tough financial hardship.There comes a variety of personal cash advance payday cash advance payday protection against you wish.Fast online you between bad credit reports a visa http://levitra6online.com http://levitra6online.com debit card associated are experiencing financial relief.Almost any fees for dealing with our company buy levitra online buy levitra online verifies all loan approved on credit.An alternative to really repay with cialis 3 pills free coupon cialis 3 pills free coupon online online payment arrangements.Depending on the results by telephone number and how to use viagra how to use viagra interest rates those already have.Fortunately when people cannot wait days http://viagra5online.com http://viagra5online.com if your regular basis?Get a complication in for us anything like they were http://wwwcialiscomcom.com/ http://wwwcialiscomcom.com/ too much you right from any contracts.
Business Insider Twitter list or anything, it's got a wide range of very smart folks, but it doesn't have that many traders. There are a few traders on the list, like Josh Brown and Doug Kass, but not enough. Here's a list of traders on Twitter who post actual trades. These are guys in the trenches, who have money on the
Jon Najarian said his heat seeker tool at OptionMonster identified big call buying activity in Inhibitex. Well, what happened over the weekend? Oh, not too much, just Bristol Myers announcing they were purchasing Inhibitex for 2.5 million, $26 a share. Inhibitex was trading for
tweeted this gem about Gilead Sciences' purchase of Pharmasset for close to $11 billion. If you owned the stock you got an 85% return. If you owned the options on the stock you were up 3,300% after today's news. Wow! Pharmassett has the stock ticker VRUS. Update: Turns out some of these Pharmassett option buys might just be too good to be true. Meaning, these options buyers knew
After a poor earnings release due to weaker-than-expected trading revenue and fears about the company's exposure to European debt (rumored to be upwards of $6 billion), the stock plummeted. Yes, the entire market cap for the company wasn't even worth $1 billion a few days
This might have something to do with a picture of a down on his luck looking Howard Lindzon (Not really him of course), that was tweeted around and commented upon by Pete Najarian. There were these earlier tweets by Lindzon a few weeks ago as well, aimed directly at the Najarian brothers. Again, I don't know the history of this feud, but I'm
Option Monster Jon Najarian is not a buyer right now – but only because he wants a bigger pullback before jumping in. “I’m a buyer of big fear,” he says. “Buy the big dips not the little piddly stuff we’re seeing. I want more fear but then I’d buy.”Source:
via Twitter along the way, with pictures of Times Square and sunsets as he travels back and forth from New York and Chicago. Sometimes
aapl amanda drury apple apple stock bac bank of america Ben Bernanke ben bernanke's beard bernie madoff bloomberg charlie rose cnbc cramer crushed david einhorn doug kass downgrades dr. doom facebook facebook ipo fast money Goldman Sachs insider trading james altucher jamie dimon jim cramer jon corzine jon najarian jp morgan lloyd blankfein mad money maria bartiromo mark zuckerberg morgan stanley Netflix nonsense Nouriel Roubini occupy wall street research in motion RIMM short squeeze stock market wall street warren buffett winners
Trade Commission Free for 30 Days at tradeMONSTER!* See Why Thousands of Traders are Making the Switch.